Nerv
Minerave Neurosciences is heating things up. NERVZig zag, followed by a correction on a correction. We are yet still to move up on this one. Goals in green, folks. GO Green!
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
NERV - The Evolution of a Soup Spoon - Part 1This is a Pre-Covid, Pre-Fall...Chart Analysis of Minerva Neurosciences
Why? ...you might ask
Because the past predicts the future with some of these stocks. NERV happens to have a unique and fun pattern.
This stock absolutely has a defined pattern that has been getting more aggressive over time.
I didn't reach back further than the PIPE...it MAY even pre-exist the PIPE.
PIPE - basically a modified Cup&Handle where the handle is at an Angle upwards. The PIPE has the flattest, slowest handle.
LADLE - handle gets steeper (the really good technical analysts saw something they liked)
SOUP SPOON - surely, tech-ies flaunted their secret knowledge when it worked out well for them. Those of us less gifted simply copied their homework. Many more people caught on. Handle was at a much more aggressive angle with a fantastic pay-off.
Then something unexpected happened...NERV had a BIG setback with their prize product. It didn't make it across the finish line as was expected. The final Clinical Trial results revealed that it was not effective enough.
It took a nose-dive...from 16 to 3...seemingly ruining its unique little pattern
Did this mean the end for our Soup Spoon?
Check out Part 2...the next one pays off.
NERV Technical Analysis.Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It primarily focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301.
If you understand the idea,🎯 press a thumb up! 👍👍👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
New Pick OBLN. High Risk – Entry 1/2 – Stop 20%23,513,292 shares of Common Stock outstanding as of December 31, 2018.
Interwest Venture Management Co is the largest institutional owner
Tamarack Advisers, LP reported adding it to their portfolio on 9/30/18
Social media metrics are off the charts right now
THIS IS HIGH RISK!!!!!!!
**********WE ARE NOT FINANCIAL ADVISERS. THIS IS A HIGH RISK TRADE. ENTER AT OWN RISK. CONSULT A FINANCIAL ADVISER BEFORE BUYING ANY PUBLICLY TRADED SECURITY. WE DO NOT OWN THIS STOCK, NOR DO WE INTEND TO BUY THIS STOCK IN THE NEAR FUTURE. WE ARE NOT BEING PAID TO WRITE THIS OR BEING COMPENSATED IN ANYWAY *****
BYND Strong IPOBYND is in a strong and tight bull channel since the IPO. This bull trend from the open is what a trader wants to see when buying for long term investments. Last week formed a reversal attempt. When the market is strong, first reversal attempts fail 80% of the time and instead create the start of a second leg up. The bears will likely need some form of second reversal attempt like a large low 2 or failed bull breakout (they act the same), in order to increase the likelihood of reversing the bull spike. Even if there is a good bear reversal, the bulls will likely look to buy again around the 50 open. If the bear pressure is not strong, the bulls will look to form a spike and bull channel which usually forms after two legs sideways to down, and generally stem from a high 2 or wedge bull flag.
If you found this helpful please like and share! Feel free to comment or ask questions.